Inside Stanford Medicine View web version
Nov. 5, 2018
Vol. 10, No. 20
Anti-CD47 cancer therapy safe, shows promise in small clinical trial

Anti-CD47 cancer therapy safe, shows promise in small clinical trial

An immunotherapy conceived at Stanford appeared safe in an early clinical trial. Half of the participants responded positively to the treatment, aimed at triggering macrophages to engulf cancer cells, the researchers reported.

 
 
Stanford, Apple describe heart study with over 400,000 participants
 

Stanford, Apple describe heart study with over 400,000 participants

Over 400,000 people have enrolled in a study being conducted by researchers at Stanford and Apple to determine whether a wearable technology can identify irregular heart rhythms suggestive of atrial fibrillation.

 
Genes behind rapid deer antler growth, hardening identified
 

Genes behind rapid deer antler growth, hardening identified

Stanford scientists and their collaborators have identified two key genes responsible for the rapid growth of deer antlers. They hope their insights will open the door to new approaches for treating bone diseases and fractures.

 
Older fathers associated with increased birth risks
 

Older fathers associated with increased birth risks

From the data of more than 40 million births, scientists at Stanford have linked paternal age to birth risks, and even risks to the mother’s health.

 
Study identifies link between DNA-protein binding, cancer onset
 

Study identifies link between DNA-protein binding, cancer onset

Understanding when and where proteins bind to DNA may be the ticket to identifying cancer at the cellular level, according to researchers at Stanford.

 
Heart recipient: ‘Stanford has saved my life not once, but twice’
 

Heart recipient: ‘Stanford has saved my life not once, but twice’

Just 28 when she received a new heart at Stanford Hospital in 1991, Yolanda Ishaq went on to become the first heart transplant recipient to have a child at Stanford.

 
Stanford Children’s Health selects new president and CEO

Stanford Children’s Health selects new president and CEO

Paul King will become the president and CEO of Stanford Children’s Health in early 2019.

 

  

  

Of note

A roundup of recent honors and awards. In this issue, read about Gregory Bean, Laramie Duncan, Derrick Wan and others.


Inside Stanford Medicine is a twice-monthly newspaper that reports on the accomplishments and activities of the faculty, staff and students in the Stanford Medicine community. To suggest a story or to get more information, contact editor John Sanford at (650) 723-8309 or jsanford@stanford.edu.

You're receiving this newsletter because you registered with us. Not interested anymore? Unsubscribe here.

Copyright © 2020 Stanford University